Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4180.70 +0.2% SILVER 57.37 +0.4% COPPER 6.56 +0.1% OIL 98.60 +0.6% PALLADIUM 1116.25 −1.1% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.650 +0.0% LIB 0.700 −2.8% NPR 0.640 +3.2% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.352 +3.7% PHNM 0.345 +1.5% SLG 5.66 −1.0% CASA 0.065 +8.3% DRY 0.220 +2.3% SOMA 0.560 +0.0% GOLD 4180.70 +0.2% SILVER 57.37 +0.4% COPPER 6.56 +0.1% OIL 98.60 +0.6% PALLADIUM 1116.25 −1.1% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.650 +0.0% LIB 0.700 −2.8% NPR 0.640 +3.2% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.352 +3.7% PHNM 0.345 +1.5% SLG 5.66 −1.0% CASA 0.065 +8.3% DRY 0.220 +2.3% SOMA 0.560 +0.0%

Cannabis

Page 48
  1. Nov 25, 2025 · 07:00 · CRON

    Cronos Launches Premium Lord Jones Live Resin Fusions(TM) in Canada

    Cronos Launches Premium Lord Jones Live Resin Fusions(TM) in Canada

    01
  2. Nov 25, 2025 · 06:00 · OGI

    Organigram Announces Appointment of Chief Executive Officer

    Organigram Announces Appointment of Chief Executive Officer

    02
  3. Nov 24, 2025 · 12:40 · TLRY

    Tilray launches Good Supply vapes in Quebec

    Tilray launches Good Supply vapes in Quebec

    03
  4. Nov 24, 2025 · 07:00 · TLRY

    Tilray Unveils Good Supply Vapes in Quebec Following the Recent Introduction of Vape Products in Quebec

    Tilray Unveils Good Supply Vapes in Quebec Following the Recent Introduction of Vape Products in Quebec

    04
  5. Nov 24, 2025 · 07:00 · LOVE

    Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings

    Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings

    05
  6. Nov 21, 2025 · 16:30 · SNDL

    SNDL Announces Renewal of Share Repurchase Program

    SNDL Announces Renewal of Share Repurchase Program

    06
  7. Nov 20, 2025 · 16:32 · VEXT

    CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results

    CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results

    07
  8. Nov 20, 2025 · 12:09 · VEXT

    Vext Science has EBITDA of $2.31M (U.S.) in Q3 2025

    Vext Science has EBITDA of $2.31M (U.S.) in Q3 2025

    08
  9. Nov 20, 2025 · 06:42 · NTLX

    SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

    SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

    09
  10. Nov 20, 2025 · 06:31 · VEXT

    Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million

    Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million

    10
  11. Nov 19, 2025 · 18:05 · HEMP

    Hempalta arranges $2-million financing, plans rollback

    Hempalta arranges $2-million financing, plans rollback

    11
  12. Nov 19, 2025 · 17:23 · TRIP

    Red Light ships five kg psilocybin to Irvine Labs

    Red Light ships five kg psilocybin to Irvine Labs

    12
  13. Nov 19, 2025 · 16:58 · AVCN

    Avicanna shows improved absorption in Pwdrx studies

    Avicanna shows improved absorption in Pwdrx studies

    13
  14. Nov 19, 2025 · 15:00 · PLCN

    Cannibble arranges $250,000 (U.S.) note financing

    Cannibble arranges $250,000 (U.S.) note financing

    14
← Newer Older →